Showing 1 - 10 of 43
Arzneimittel zur Behandlung dieser Krankheit. Zum anderen wurde auch der Mangel wirksamer Medikamente gegen vernachlässigte … Immatrialgüterrechte wesentliche Vorraussetzung für die konstante Entwicklung innovativer Arzneimittel seien. Kritiker des TRIPS … Arzneimittel gegen vernachlässigte Krankheiten bis zum 30.06.2008 überprüft. Unter Berücksichtigung des kurzfristigen …
Persistent link: https://www.econbiz.de/10009475357
A collection of eighteen articles have been purposely chosen to demonstrate the development of the original and significant contributions of my research over the period 1990 to 2008. Despite the relatively large number of articles, which cover a range of related issues, there is a surprisingly...
Persistent link: https://www.econbiz.de/10009457368
Die Arbeit untersucht den Einfluss der Genehmigung von Medikamenten durch die amerikanische Zulassungsbehörde FDA (Food and Drug Administration) auf den Aktienkurs der Antrag stellenden Aktiengesellschaft. Dabei werden Genehmigungen von wichtigen pharmazeutischen und biopharmazeutischen...
Persistent link: https://www.econbiz.de/10009450191
This dissertation examines the evolution of the market and the firms in the context of an emerging innovative race in the U.S. pharmaceutical industry. The history shows the existence of two distinct industry regimes. Before 1940, the industry can best be characterized as a competitive regime in...
Persistent link: https://www.econbiz.de/10009439017
Strategic alliances are of critical importance to firms working in the health biotechnology2 field. Collaborations can provide firms with significant competitive advantages, shape their economic performance and help minimize risks in development activities (Hagedoorn, 1993). Alliances in the...
Persistent link: https://www.econbiz.de/10009475749
This paper investigates the influence of human resource management practices on the likelihood that a firm performs in-house R&D. The latter is broadly interpreted as learning---a mechanism promoting absorptive capacity and supporting technology capability-building in latecomer firms. The use of...
Persistent link: https://www.econbiz.de/10009476008
pharmaceuticals- biotechnologysectors. It is built on the premise that ceteris paribus participation of Indian firms in IPcreation and …
Persistent link: https://www.econbiz.de/10009476130
Šiame darbe stengiamasi išanalizuoti farmacijos pramonės etines problemas ir pateikti galimus šių problemų sprendimo būdus bei ateities perspektyvas. Farmacijos produktų specifika nulemia farmacijos kompanijų moralinių ir socialinių pareigų visumą ir įpareigoja kompanijas ne tik...
Persistent link: https://www.econbiz.de/10009479276
Chapter 1: The Economic Effects of Medical Innovations: Vioxx and Labor SupplyDespite dramatic improvements in medical technology over time, comparatively little attention has been paid to the effect of these innovations on economic outcomes. This study uses seven overlapping panels of the...
Persistent link: https://www.econbiz.de/10009450754
government.The first paper estimates the price elasticity of demand for pharmaceuticals amongst high-income older people in …
Persistent link: https://www.econbiz.de/10009484210